Int J Nanomedicine. 2026 Jan 8;21:558908. doi: 10.2147/IJN.S558908. eCollection 2026.
ABSTRACT
Peripheral nerve injury remains a major clinical challenge due to inefficient axonal regeneration and limited therapeutic options. As central regulators of the repair process, macrophages dynamically transition from a pro-inflammatory to a pro-regenerative phenotype, coordinating debris clearance, axonal regrowth, remyelination, and functional restoration. However, disruptions in macrophage polarization-particularly in aging or chronic injury contexts-compromise regenerative outcomes. Here, we present a comprehensive overview of nano-immunomodulatory strategies designed to precisely direct macrophage fate for targeted peripheral nerve repair. Engineered organic, inorganic, and topography-guided nanoparticles provide spatiotemporal control of macrophage behavior via surface modifications and responsive designs, enabling phenotype reprogramming, microenvironment remodeling, and synergistic interactions with Schwann cells and regenerating axons. To present a balanced perspective, we also highlight key translational barriers-including long-term biocompatibility, immune safety, large-scale manufacturing, and regulatory challenges-that currently limit clinical application. This review highlights nano-immunomodulation as a promising approach for modulating immune-neural interfaces, offering a path toward precision therapies for peripheral nerve injury.
PMID:41847177 | PMC:PMC12990240 | DOI:10.2147/IJN.S558908